Qiagen (NYSE:QGEN – Get Free Report) was the target of a significant drop in short interest during the month of April. As of April 15th, there was short interest totalling 2,960,000 shares, a drop of 16.9% from the March 31st total of 3,560,000 shares. Approximately 1.3% of the company’s shares are short sold. Based on an average daily volume of 1,010,000 shares, the days-to-cover ratio is currently 2.9 days.
Qiagen Stock Up 1.4 %
Shares of NYSE QGEN traded up $0.59 during midday trading on Monday, reaching $42.24. 953,718 shares of the company’s stock were exchanged, compared to its average volume of 1,187,453. Qiagen has a 52-week low of $34.74 and a 52-week high of $47.70. The stock has a market capitalization of $9.64 billion, a PE ratio of 27.53, a price-to-earnings-growth ratio of 3.51 and a beta of 0.41. The company has a debt-to-equity ratio of 0.24, a quick ratio of 1.62 and a current ratio of 1.99. The business’s fifty day moving average price is $42.58 and its two-hundred day moving average price is $42.68.
Qiagen (NYSE:QGEN – Get Free Report) last announced its quarterly earnings data on Tuesday, February 6th. The company reported $0.55 earnings per share for the quarter, meeting the consensus estimate of $0.55. The firm had revenue of $509.00 million during the quarter, compared to analyst estimates of $500.77 million. Qiagen had a return on equity of 12.99% and a net margin of 17.37%. During the same period in the previous year, the company earned $0.53 earnings per share. Analysts forecast that Qiagen will post 2.09 EPS for the current year.
Analyst Ratings Changes
Read Our Latest Research Report on QGEN
Institutional Trading of Qiagen
Several hedge funds and other institutional investors have recently bought and sold shares of QGEN. Norges Bank bought a new stake in Qiagen in the fourth quarter valued at about $264,322,000. Wellington Management Group LLP boosted its stake in Qiagen by 81.0% in the third quarter. Wellington Management Group LLP now owns 6,054,116 shares of the company’s stock valued at $245,299,000 after acquiring an additional 2,709,030 shares during the period. Massachusetts Financial Services Co. MA boosted its stake in Qiagen by 8.1% in the fourth quarter. Massachusetts Financial Services Co. MA now owns 24,066,569 shares of the company’s stock valued at $1,045,211,000 after acquiring an additional 1,809,486 shares during the period. Allspring Global Investments Holdings LLC boosted its stake in Qiagen by 33,220.7% in the fourth quarter. Allspring Global Investments Holdings LLC now owns 1,345,488 shares of the company’s stock valued at $58,435,000 after acquiring an additional 1,341,450 shares during the period. Finally, Nuance Investments LLC acquired a new position in Qiagen in the fourth quarter valued at approximately $47,479,000. 70.00% of the stock is owned by institutional investors.
Qiagen Company Profile
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, including kits and components for purification of nucleic acids from secondary sample materials; and instruments for nucleic acid purification and accessories.
Featured Articles
- Five stocks we like better than Qiagen
- 3 Monster Growth Stocks to Buy Now
- What Bulls and Bears May Be Getting Wrong about SOFI Stock
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Microsoft Analysis: Trends, Predictions & Investment Insight
- Most Volatile Stocks, What Investors Need to Know
- onsemi: The Rebound is ON for This Chip Stock
Receive News & Ratings for Qiagen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Qiagen and related companies with MarketBeat.com's FREE daily email newsletter.